Issue 17 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

22

No.

17

April 26, 1996Apr 26, 1996

Free

DOWNLOAD THE PDF

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

Centers May Become More specialized, Klausner Tells AACI

NIH, NCI Being Discussions With HCFA On Reimbursement

Recent Issues

Volume 52 | Issue 35 - September 25, 2026

Volume 52 | Issue 34 - September 18, 2026

Volume 52 | Issue 33 - September 11, 2026

Volume 52 | Issue 32 - August 14, 2026

Volume 52 | Issue 31 - August 07, 2026

Volume 52 | Issue 30 - July 31, 2026